Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-26Clinical Trial Update: Allogeneic Transplantation From Related Haploidentical Donors [Phase 2]
A Phase 2 clinical trial evaluating allogeneic transplantation from related haploidentical donors for blood cancers and leukemia has complet…
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas [Phase 1]
Phase 1 study evaluating CHOP chemotherapy plus Campath-1H (alemtuzumab) as initial treatment for untreated aggressive T/NK-cell non-Hodgkin…
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating combination chemotherapy plus Rituximab and radiation therapy in patients with Stage I or Stage II Non-Hodgkin's …
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Safety Study of HBI-8000 in Japanese Patients With Non Hodgkin's Lymphoma [Phase 1]
Phase 1 safety study evaluating HBI-8000 in Japanese patients with Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Study of LBH589, A Deacetylase Inhibitor in Patients With Recurrent or Refractory Hodgkin or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study of LBH589 (panobinostat) in patients with recurrent or refractory Hodgkin lymphoma or non-Hodgkin lymphoma has been terminated…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-01-10Clinical Trial Update: Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy [Phase 4]
Phase 4 clinical trial investigates prophylactic entecavir to prevent hepatitis B reactivation in HBsAg-positive lymphoma patients treated w…
-
CLINICAL_TRIALS trial_result · 2016-12-23Clinical Trial Update: Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study evaluating a combination of bortezomib, rituximab, and yttrium-90 ibritumomab tiuxetan in relapsed or refractory low-grade, fo…
-
CLINICAL_TRIALS research · 2016-12-21Clinical Trial Update: To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma [Phase 4]
This clinical trial update notes a Phase 4 study comparing the duration of prophylactic Tenofovir use in patients with Non-Hodgkin lymphoma,…
-
FDA approval · 2016-12-20FDA Approved: TREXALL — Supplemental Application (Teva Women's Health, Inc.)
FDA approved a supplemental application for TREXALL (methotrexate) from Teva Women's Health, Inc.
-
CLINICAL_TRIALS research · 2016-12-19Clinical Trial Update: PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia [Phase 4]
Phase 4 clinical trial evaluating PEG-rhG-CSF (pegfilgrastim) to prevent chemotherapy-induced neutropenia in patients with Non-Hodgkin lymph…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma [Phase 2]
This Phase 2 trial assesses the effectiveness of fludarabine plus octreotide in patients with relapsed low-grade Non-Hodgkin lymphoma. The s…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Retrospective Analysis on Relapsed/Refractory Aggressive Non Hodgkin Lymphoma Treated With Z-BEAM Plus ASCT
A retrospective analysis of patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma treated with Z-BEAM conditioning follow…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating rituximab plus cladribine for newly diagnosed non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating the combination of chemotherapy with rituximab for relapsed non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma [Phase 1]
An early-phase (Phase I/II) study of Abraxane in recurrent and refractory lymphoma was terminated. The trial involved non-Hodgkin lymphoma a…
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701) [Phase 2]
Phase 2 trial assessing blood stem cell transplant with low-dose chemotherapy for relapsed follicular non-Hodgkin's lymphoma (BMT CTN 0701) …
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL) [Phase 4]
Phase 4 expanded access program update for pegfilgrastim (Neulastim) in participants with non-Hodgkin's lymphoma, now completed.
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT) [Phase 1]
Phase 1 trial update of immunostimulatory CpG SD-101 plus radiation therapy for recurrent/progressive lymphoma after allogeneic hematopoieti…
-
CLINICAL_TRIALS trial_result · 2016-11-17Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN) [Phase 3]
Phase 3 trial comparing bendamustine alone to bendamustine plus obinutuzumab in rituximab-refractory indolent non-Hodgkin's lymphoma complet…
-
CLINICAL_TRIALS trial_result · 2016-11-11Clinical Trial Update: Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma [Phase 2]
Phase 2 trial of BEAM chemotherapy regimen followed by autologous stem cell transplantation for lymphoma is completed; results were posted i…
-
CLINICAL_TRIALS research · 2016-11-09Clinical Trial Update: Incidence of Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients [NA]
This clinical trial update examines the incidence of hepatitis B reactivation in patients with non-Hodgkin's lymphoma.
-
CLINICAL_TRIALS withdrawal · 2016-11-08Clinical Trial Update: Prospective Study of Lymphoproliferative Diseases
This clinical trial update notes that the prospective study of lymphoproliferative diseases sponsored by West Virginia University has been w…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating Rituximab (MabThera/Rituxan) in patients with non-bulky follicular non-Hodgkin's lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study Evaluating GDC-0980 Administered Once Daily in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 trial evaluating GDC-0980 in patients with refractory solid tumors or Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Evaluating the Safety and Tolerability of GDC-0349 in Patients With Locally Advanced or Metastatic Solid Tumors or Non Hodgkin's Lymphoma [Phase 1]
A completed Phase 1 trial evaluating the safety and tolerability of GDC-0349 in patients with locally advanced or metastatic solid tumors or…